National Health Investors (NHI) Ratios
National Health Investors Ratios
MX:NHI's free cash flow for Q2 2026 was $68.33M. For the 2026 fiscal year, MX:NHI's free cash flow was increased by $2.90M and operating cash flow was $65.44M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.48 | 0.96 | 1.16 | 3.42 | 7.34 |
| Quick Ratio | 2.48 | 0.96 | 1.16 | 3.42 | 7.34 |
| Cash Ratio | 0.16 | 0.06 | 0.07 | 0.17 | 0.53 |
| Solvency Ratio | 0.18 | 0.17 | 0.17 | 0.11 | 0.15 |
| Operating Cash Flow Ratio | 1.92 | 0.50 | 0.57 | 1.65 | 3.00 |
| Short-Term Operating Cash Flow Coverage | 1.92 | 0.63 | 0.75 | 4.41 | 0.00 |
| Net Current Asset Value | $ -946.76M | $ -832.28M | $ -839.24M | $ -834.51M | $ -807.11M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.42 | 0.44 | 0.46 | 0.46 | 0.44 |
| Debt-to-Equity Ratio | 0.76 | 0.84 | 0.91 | 0.90 | 0.83 |
| Debt-to-Capital Ratio | 0.43 | 0.46 | 0.48 | 0.47 | 0.45 |
| Long-Term Debt-to-Capital Ratio | 0.41 | 0.37 | 0.42 | 0.47 | 0.45 |
| Financial Leverage Ratio | 1.84 | 1.91 | 1.98 | 1.97 | 1.88 |
| Debt Service Coverage Ratio | 1.55 | 0.68 | 0.86 | 2.12 | 5.01 |
| Interest Coverage Ratio | 3.40 | 3.28 | 3.22 | 3.13 | 3.85 |
| Debt to Market Cap | 0.33 | 0.38 | 0.47 | 0.49 | 0.47 |
| Interest Debt Per Share | 26.05 | 27.42 | 27.44 | 26.58 | 28.43 |
| Net Debt to EBITDA | 4.06 | 4.25 | 4.28 | 6.31 | 5.04 |
| Profitability Margins | |||||
| Gross Profit Margin | 36.70% | 96.67% | 96.40% | 96.48% | 96.10% |
| EBIT Margin | 52.35% | 57.50% | 59.37% | 38.77% | 53.61% |
| EBITDA Margin | 74.50% | 78.81% | 81.25% | 64.25% | 80.66% |
| Operating Profit Margin | 51.47% | 54.85% | 55.90% | 47.72% | 62.02% |
| Pretax Profit Margin | 37.19% | 40.75% | 42.02% | 23.51% | 37.50% |
| Net Profit Margin | 37.56% | 41.17% | 42.41% | 23.87% | 37.43% |
| Continuous Operations Profit Margin | 37.19% | 40.77% | 42.02% | 23.55% | 37.48% |
| Net Income Per EBT | 100.99% | 101.02% | 100.95% | 101.52% | 99.80% |
| EBT Per EBIT | 72.26% | 74.29% | 75.16% | 49.27% | 60.48% |
| Return on Assets (ROA) | 5.08% | 5.28% | 5.45% | 2.65% | 3.94% |
| Return on Equity (ROE) | 9.34% | 10.10% | 10.82% | 5.23% | 7.42% |
| Return on Capital Employed (ROCE) | 7.29% | 8.36% | 8.26% | 5.54% | 6.69% |
| Return on Invested Capital (ROIC) | 6.97% | 7.26% | 7.42% | 5.45% | 6.69% |
| Return on Tangible Assets | 5.08% | 5.28% | 5.45% | 2.65% | 3.94% |
| Earnings Yield | 3.97% | 4.54% | 5.60% | 2.84% | 4.26% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.30 | 0.90 | 0.93 | 0.87 | 0.73 |
| Payables Turnover | 0.00 | 0.30 | 0.34 | 0.38 | 0.50 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.14 | 0.13 | 0.13 | 0.11 | 0.11 |
| Working Capital Turnover Ratio | 4.51 | 20.09 | 1.99 | 0.78 | 1.15 |
| Cash Conversion Cycle | 280.21 | -830.97 | -693.18 | -548.54 | -227.38 |
| Days of Sales Outstanding | 280.21 | 403.36 | 394.37 | 417.47 | 499.64 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 1234.33 | 1087.55 | 966.01 | 727.02 |
| Operating Cycle | 280.21 | 403.36 | 394.37 | 417.47 | 499.64 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.12 | 4.75 | 4.25 | 4.14 | 4.61 |
| Free Cash Flow Per Share | 4.70 | 4.39 | 4.16 | 4.04 | 4.61 |
| Dividend Paid and CapEx Coverage Ratio | 1.27 | 1.21 | 1.15 | 1.11 | 1.15 |
| Capital Expenditure Coverage Ratio | 12.03 | 13.23 | 49.28 | 40.04 | 3294.67 |
| Operating Cash Flow Coverage Ratio | 0.21 | 0.18 | 0.16 | 0.16 | 0.17 |
| Operating Cash Flow to Sales Ratio | 0.63 | 0.62 | 0.58 | 0.67 | 0.71 |
| Free Cash Flow Yield | 6.15% | 6.33% | 7.46% | 7.73% | 8.02% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 25.20 | 22.07 | 17.86 | 35.21 | 23.50 |
| Price-to-Sales (P/S) Ratio | 9.46 | 9.07 | 7.58 | 8.40 | 8.79 |
| Price-to-Book (P/B) Ratio | 2.35 | 2.22 | 1.93 | 1.84 | 1.74 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 16.25 | 15.79 | 13.41 | 12.94 | 12.46 |
| Price-to-Operating Cash Flow Ratio | 14.90 | 14.60 | 13.14 | 12.62 | 12.46 |
| Price-to-Earnings Growth (PEG) Ratio | -7.19 | 69.08 | 0.04 | -0.57 | -0.43 |
| Enterprise Value Multiple | 16.75 | 15.75 | 13.61 | 19.39 | 15.94 |
| Enterprise Value | 4.72B | 4.16B | 3.54B | 3.47B | 3.84B |
| EV to EBITDA | 16.75 | 15.75 | 13.61 | 19.39 | 15.94 |
| EV to Sales | 12.48 | 12.41 | 11.06 | 12.46 | 12.86 |
| EV to Free Cash Flow | 21.45 | 21.62 | 19.57 | 19.18 | 18.22 |
| EV to Operating Cash Flow | 19.66 | 19.98 | 19.17 | 18.70 | 18.22 |
| Tangible Book Value Per Share | 32.85 | 31.59 | 29.36 | 28.81 | 33.18 |
| Shareholders’ Equity Per Share | 32.46 | 31.17 | 28.90 | 28.37 | 32.97 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | 0.00 | -0.00 | 0.00 |
| Revenue Per Share | 8.08 | 7.64 | 7.37 | 6.21 | 6.53 |
| Net Income Per Share | 3.03 | 3.15 | 3.13 | 1.48 | 2.45 |
| Tax Burden | 1.01 | 1.01 | 1.01 | 1.02 | 1.00 |
| Interest Burden | 0.71 | 0.71 | 0.71 | 0.61 | 0.70 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.07 | 0.06 | 0.09 | 0.06 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.03 | 0.03 |
| Income Quality | 1.69 | 1.51 | 1.37 | 2.83 | 1.88 |
Currency in USD